| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |